8.14
2.05%
-0.17
Handel nachbörslich:
8.14
Schlusskurs vom Vortag:
$8.31
Offen:
$8.27
24-Stunden-Volumen:
270.44K
Relative Volume:
0.50
Marktkapitalisierung:
$500.09M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-3.0373
EPS:
-2.68
Netto-Cashflow:
$-17.32M
1W Leistung:
-0.73%
1M Leistung:
+13.21%
6M Leistung:
+8.10%
1J Leistung:
-19.57%
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-08-05 | Herabstufung | Stifel | Buy → Hold |
2022-04-14 | Eingeleitet | Guggenheim | Buy |
2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
2022-02-11 | Eingeleitet | Goldman | Buy |
2021-12-02 | Eingeleitet | Jefferies | Hold |
2021-10-14 | Eingeleitet | BTIG Research | Buy |
2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
2020-12-08 | Eingeleitet | Berenberg | Buy |
2020-07-14 | Eingeleitet | Citigroup | Buy |
2020-06-18 | Eingeleitet | Stifel | Buy |
2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
2020-05-15 | Eingeleitet | Guggenheim | Buy |
2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
2019-08-19 | Eingeleitet | Goldman | Buy |
2019-08-19 | Eingeleitet | JP Morgan | Overweight |
2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
2019-08-19 | Eingeleitet | SunTrust | Buy |
2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Short Interest in Health Catalyst, Inc. (NASDAQ:HCAT) Grows By 7.3% - MarketBeat
Healthcare Medical Analytics Market Overall Study Report - openPR
Daventry Group LP Increases Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets (NASDAQ:HCAT) - Seeking Alpha
Inspire Investing LLC Grows Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
First Light Asset Management LLC Grows Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst (NASDAQ:HCAT) Given Overweight Rating at Cantor Fitzgerald - MarketBeat
Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts - Benzinga
Primecap Management Co. CA Raises Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Healthcare Analytics Market Dynamics: In-Depth Trends, Share - openPR
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells 1,324 Shares of Stock - Defense World
Health Catalyst exec sells over $11k in company stock By Investing.com - Investing.com South Africa
Health Catalyst exec sells over $11k in company stock By Investing.com - Investing.com Canada
Health Catalyst exec sells over $11k in company stock - Investing.com India
Health Catalyst exec sells over $11k in company stock By Investing.com - Investing.com UK
Los Angeles Capital Management LLC Has $1.37 Million Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Bought by Acadian Asset Management LLC - Defense World
Improving Outcomes and Lowering the Cost of Care - MarketScale
Health Catalyst CFO sells shares worth over $21,000 - Investing.com
Health Catalyst general counsel sells over $18,000 in company stock - Investing.com
Health Catalyst CFO sells shares worth over $21,000 By Investing.com - Investing.com Australia
Health Catalyst general counsel sells over $18,000 in company stock By Investing.com - Investing.com Australia
Health Catalyst CFO sells shares worth over $21,000 By Investing.com - Investing.com South Africa
Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Health Catalyst CFO sells shares worth over $21,000 - Investing.com India
Health Catalyst general counsel sells over $18,000 in company stock - Investing.com India
Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 2,466 Shares - MarketBeat
Health Catalyst general counsel sells over $18,000 in company stock By Investing.com - Investing.com UK
Bruno Lempernesse - DOTmed HealthCare Business News
Bank of New York Mellon Corp Sells 259,263 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst COO sells over $61k in company stock By Investing.com - Investing.com Australia
Health Catalyst executive sells over $54k in company stock By Investing.com - Investing.com Australia
Health Catalyst executive sells over $54k in company stock - Investing.com
Health Catalyst COO sells over $61k in company stock - Investing.com India
Health Catalyst COO sells over $61k in company stock By Investing.com - Investing.com Canada
Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells $54,150.00 in Stock - MarketBeat
Health Catalyst COO sells over $61k in company stock By Investing.com - Investing.com UK
Health Catalyst executive sells over $54k in company stock By Investing.com - Investing.com UK
JPMorgan Chase & Co. Increases Health Catalyst (NASDAQ:HCAT) Price Target to $13.00 - MarketBeat
Where are the Opportunities in (HCAT) - Stock Traders Daily
Health Catalyst shares retain buy rating, price target from Canaccord - Investing.com
Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon - Healthcare IT Today
Health Catalyst to Participate in Upcoming Investor Conferences - Yahoo Finance UK
Health Catalyst to Participate in Upcoming Investor Conferences - StockTitan
WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite - PR Newswire
Health Catalyst shares target cut, holds rating on execution questions - Investing.com
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts - Benzinga
Health Catalyst (NASDAQ:HCAT) PT Lowered to $11.00 at Piper Sandler - MarketBeat
Baillie Gifford & Co. Lowers Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst finalizes acquisition of Lumeon - Utah Business
Health Catalyst’s (HCAT) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):